In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia

Anesthesiology

Volumn 93, Issue 1, 2000, Pages 39-47

  Freymond, Daniel ^a   Dériaz, Olivier ^a   Frascarolo, Philippe ^a   Reiz, Sebastian ^a   Jéquier, Eric ^a   Urwyler, Albert ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Body composition; Family; Nutrient oxidation rate

Indexed keywords

CALCIUM; INHALATION ANESTHETIC AGENT; INSULIN; SUXAMETHONIUM;

ARTICLE; BODY COMPOSITION; CALCIUM METABOLISM; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; HORMONE ACTION; HUMAN; HUMAN TISSUE; MALIGNANT HYPERTHERMIA; PRIORITY JOURNAL;

EID: 0343628702     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200007000-00011     Document Type: Article

References (39)

1. MacLennan DH, Phillips MS: Malignant hypcrthermia. Science 1992; 256:789-94
2. The European Malignant Hyperpyrexia Group: A protocol for the investigation of malignant hyperpyrexia (MIO susceptibility. Br J Anesth 1984; 56:1267-9
3. 0rding H for the European Malignant Hyperthermia Group: In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects. Acta Anesthesiol Scand 1997; 41:955-66
4. Denborough M: Malignant hyperthermia. Lancet 1998; 352:1131-6
5. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.; Biol Chem 1997; 272(42):26332-9
6. 2+ release channels. J Biol Chem 1999; 274(2):693-702
7. Rutberg H, Hakanson E, Hall GM, Jorfeldt L: Effects of graded exercise on leg exchange of energy substrates in malignant hyperthermia susceptible subjects. A.NESTHESIOLOGY 1987; 67:308-13
8. Campbell IT, Ellis FR, Evans RT: Metabolic rate and blood hormone and metabolite levels of individuals susceptible to malignant hyperpyrexia at rest and in response to food and mild exercise. ANESTHESIOLOGY 1981; 55:46-52
9. Denborough MA, Warne GL, Moulds RFW, Tse P, Martin FIR: Insulin secretion in malignant hyperpyrexia. Br Med J 1974; 3:493-5
10. Willner JH, Wood DS, Cerri C, Bit B: Increased myophosphorylase a in malignant hyperthermia. N Engl J Med 1980; 303(3):138-40
11. 2+] measured in vivo in patients susceptible to malignant hyperthermia. A.NESTHESIOLOGY 1992; 76:711-9
12. Shulman GI, Rothman DL, Jue T, Stein P, De Fronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by I3C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322(4):223-8
13. Lee AD, Gulve EA, Chen M, Schluter J, Holloszy JO: Effects of Ca24" ionophore ionomycin on insulin-stimulated and basal glucose transport in muscle. Am J Physiol 1995; 268:R997-1002
14. Green JH, Ellis FR, Halsall PJ, Campbell IT, Currie S, Caddy J: Thermorégulation, plasma catecholamine and metabolite levels during submaximal work in individuals susceptible to malignant hyperpyrexia. Acta Anesthesiol Scand 1987; 31:122-6
15. Olgin J, Argov Z, Rosenberg H, Tuchler M, Chance B: Noninvasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. ANESTHESIOLOGY 1988; 68:507-13
16. Payen JF, Bosson JL, Bourdon L, Jacquot C, Le BasJF, Stieglitz P, Benabid AL: Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31-P magnetic resonance spectroscopy. ANESTHESIOLOGY 1993; 78:848-55
17. Tataranni P.A., Ravussin E: Variability in metabolic rate: Biological sites of regulation. Int J Obes 1995; 19(suppl 4):S102-6
18. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WGH, Boyce V, Howard BV, Bogardus C: Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318(8):467-72
19. De Fronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E2l4-23
20. Jéquier E, Acheson K, Schutz Y: Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 1987; 7:187-208
21. Unvyler A, Censier K, Kaufmann MA, Drewe J: Genetic effects on the variability of the halothane and caffeine muscle contracture tests. ANESTHESIOLOGY 1994; 80:1287-95
22. Durning JVGA, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged 16-72 years. Br J Nutr 1974; 32:77-97
23. Lukaski HC: Methods for tfie assessment of human body composition: Traditional and new. Am J Clin Nutr 1985; 46:537-56
24. Bracco D, Thiébaud D, Chioléro RL, Landry M, Burckhardt P, Schutz Y: Segmentai body composition assessed by bioelectrical im-pedance analysis and DEXA in humans. J Appl Physiol 1996; 81(6): 2580-7
25. Tounian P, Schneiter Ph, Henry S, Jéquier E, Tappy L: Effects of infused fructose on endogenous glucose production, gluconeogenesis, and glycogen metabolism. Am J Physiol 1994; 267:E710-7
26. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 1988; 37(8):1025-34
27. Jéquier E, Felber JP: Indirect calorimetry. Bailleres Clin EndocrinoIMetab 1987; 1:911-35
28. Tappy L, Owen O, Boden G: Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 1988; 37:1212-7
29. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sei 1959; 82:420-30
30. Hawk P: The Kjeldahl method, Practical Physiology Chemistry. Edited by Hawk PB, Oser BL, Simonson WH. Toronto, Blackiston Publishers, 1947, pp 814-22
31. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25:1375-84
32. Thiébaud D, Schutz Y, Acheson K, Jacot E, De Fronzo RA, Felber JP, Jéquier E: Energy cost of glucose storage in human subjects during glucose-insulin infusions. Am J Physiol 1983; 244:E216-21
33. Campbell IT, Ellis FR, Halsall PJ, Hogge MS: Anthropométrie studies of human subjects susceptible to malignant hyperpyrexia. Acta Anaesth Scand 1982; 26(4):363-7
34. Zurlo F, Larson K, Bogardus C, Ravussin E: Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990; 86:1423-7
35. 2+-dependent heat production under basal and near-basal conditions in the mouse soleus muscle. J Physiol 1992; 455:663-78
36. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA: Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 1988; 82:1848-52
37. 2+ in isolated skeletal muscle. Proc Natl Acad Sei U S A 1999; 96:3281-6
38. 2+] in human skeletal muscle. Cell Calcium 1989; 10:151-8
39. Censier K, Urwyler A, Zorzato F, Trêves S: Intracellular calcium homeostasis in human primary- muscle cells from malignant hyperthermia-susceptible and normal individuals. J Clin Invest 1998; 101:1233-42